Overview

Dialysis Market is estimated to value over CAGR of over 6% during the forecast period 2022 to 2028.

Dialysis is used for filtering blood to balance the fluid and electrolyte levels in patients diagnosed with kidney dysfunction. This method has to be used when the kidneys are functioning less than 10 percent of normal. Dialysis is required during end-stage renal disease treatment and during kidney transplant.  Periodontal dialysis and haemodialysis are two primary types of dialysis that enable waste eradication and removal of excessive water from the blood. In haemodialysis, waste products like urea are eradicated from the blood while the peritoneal dialysis uses the peritoneum of the abdomen for dialysis. 
There has been a substantial rise in the number of patients diagnosed with kidney dysfunction. According to the National Kidney Foundation, in 2014, over 2 million people worldwide were diagnosed with chronic kidney failure and are undergoing dialysis currently. Such a rise in the number of kidney patients has propelled the dialysis market growth.

Market Segmentation:

By Type
•    Hemodialysis
•    Peritoneal Dialysis
By Product
•    Devices 
•    Consumables
•    Services
By End User
•    Hospital-Based Dialysis 
•    Home-Based Dialysis        
By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is categorised into type, product, end user and region. The type segment is classified into haemodialysis and peritoneal dialysis. The haemodialysis segment is further divided into conventional dialysis, nocturnal haemodialysis and short daily haemodialysis while the peritoneal dialysis segment is bifurcated into continuous ambulatory peritoneal dialysis and automated peritoneal dialysis. The peritoneal dialysis segment is predicted to hold the largest dialysis market share, and this can be due to the increased insistence for peritoneal dialysis, especially amongst children and infants. Furthermore, this method has a wide range of applications, particularly in home-based services. For instance, Baxter Inc., in April 2015, were awarded with a CE approval for launching Homechoice Claria in Europe. This device can perform peritoneal dialysis in home-based settings. The product segment is fragmented into device, consumables and services. The devices segment is further bifurcated into dialysers, water treatment systems, dialysis machines and others while consumables segment is further divided into concentrates, catheters, bloodline and others. The end user segment is classified into hospital-based and home-based dialysis. The home-based dialysis segment is anticipated to grow at a significant rate during the forecast period owing to the rising demand for home-based medical services and the rising geriatric population. The hospital-based segment, on the other hand, currently dominates the market and this is backed up by data provided by Global Dialysis which states that over 16,000 centres were set in over 160 countries in 2015. Furthermore, many key players have collaborated with major hospital chains to set up hospital-based dialysis. For example, in 2017, Fresenius Medical Care Co. collaborated with John Hopkins Hospitals in setting up over eight centres in Baltimore, U.S, owing to the rising demand for this service in the region. 

Regional Analysis:

The North America region is expected to dominate the market owing to advancement in the healthcare infrastructure, a strong presence of key players in the region, rising number of hospitals in the region. The Asia Pacific region, on the other hand, is predicted to grow at a substantial rate during the forecast period owing to a rise in the number of patient population and key players expanding their business operations in the region. 

Competitive Landscape:                            

The key players of the market associated are Fresenius Medical Care AG & Co. KGaA, B. Braun Avitum AG, NIPRO Medical Corporation, DaVita Inc., Baxter, Asahi Kasei Corporation, Kawasumi Laboratories, Medtronic, Nikkiso Co., Ltd, U.S. Renal Care. 

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global dialysis market by type, by product, by end user and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1. Objectives of the Study
  1.2. Market Definition
  1.3. Market Scope
       1.3.1. Years Considered for the Study
       1.3.2. Market Covered
  1.4. Currency
  1.5. Limitations
  1.6. Stakeholders

2. Research Methodology
  2.1. Research Data
       2.1.1. Secondary Data
              2.1.1.1. Key Data from Secondary Sources
       2.1.2. Primary Data
              2.1.2.1. Key Data from Primary Sources
  2.2. Market Size Estimation
  2.3. Market Breakdown and Data Triangulation
  2.4. Assumptions for the Study  

3. Executive Summary
  3.1. Market Outlook
  3.2. Segment Outlook
  3.3. Competitive Insights

4. Global Dialysis Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Hospital Information Systems Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Dialysis Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Dialysis Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million)
  7.1. Hemodialysis
         7.1.1.Conventional Hemodialysis
         7.1.2.Short Daily Hemodialysis
         7.1.3.Nocturnal Hemodialysis
  7.2. Peritoneal dialysis
         7.1.1.Continuous Ambulatory Peritoneal Dialysis (CAPD)
         7.1.2.Automated Peritoneal Dialysis (APD)

8. Global Dialysis Market, By Product & Service Historical Analysis and Forecast 2022-2028 (USD Million)  
  8.1. Equipment
         8.1.1.Dialysis machines
         8.1.2.Water treatment systems
         8.1.3.Others
  8.2. Consumables
         8.2.1.Dialyzers
         8.2.2.Catheters
         8.2.3.Access products
         8.2.4.Concentrates
         8.2.5.Others
  8.3. Services
         8.3.1.Chronic dialysis
         8.3.2.Acute dialysis

9. Global Dialysis Market, By End-use Historical Analysis and Forecast 2022-2028 (USD Million)  
  9.1. In-center dialysis
  9.2. Home dialysis

10. North America Dialysis Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   10.1. Introduction
   10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         10.2.1. U.S.A
         10.2.2. Canada
         10.2.3. Mexico
   10.3. Market Size (USD Million) Forecast for North America 2022-2028

11. Latin America Dialysis Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   11.1. Introduction
   11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         11.2.1. Brazil
         11.2.2. Venezuela
         11.2.3. Argentina
         11.2.4. Rest of Latin America
   11.3. Market Size (USD Million) Forecast for Latin America 2022-2028

12. Europe Dialysis Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   12.1. Introduction
   12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         12.2.1. Germany
         12.2.2. U.K        
         12.2.3. France
         12.2.4. Italy
         12.2.5. Spain
         12.2.6. Russia
         12.2.7. Poland
         12.2.8. Rest of Europe
   12.3. Market Size (USD Million) Forecast for Europe 2022-2028

13. Asia Pacific Dialysis Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   13.1. Introduction
   13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         13.2.1. Japan
         13.2.2. China
         13.2.3. India
         13.2.4. Australia and New Zealand
         13.2.5. ASEAN
         13.2.6. Rest of Asia Pacific
   13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

14. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   14.1. Introduction
   14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         14.2.1. GCC
         14.2.2. Israel
         14.2.3. South Africa
         14.2.4. Rest of MEA
   14.3. Market Size (USD Million) Forecast for MEA 2022-2028

15. Market Share Analysis and Competitive Landscape  
   15.1. Global Landscape - Key Players, Revenue and Presence
   15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   15.3. Global Emerging Companies
   15.4. North America - Market Share Analysis and Key Regional Players
   15.5. Europe - Market Share Analysis and Key Regional Players
   15.6. Asia Pacific - Market Share Analysis and Key Regional Players
   15.7. Global Key Player - Growth Matrix

16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   16.1. U.S. Renal Care
         16.1.1. Company Overview
         16.1.2. Product Portfolio
         16.1.3. SWOT Analysis
         16.1.4. Financial Overview
         16.1.5. Strategic Overview
   16.2. Toray Industries
         16.2.1. Company Overview
         16.2.2. Product Portfolio
         16.2.3. SWOT Analysis
         16.2.4. Financial Overview
         16.2.5. Strategic Overview
   16.3. Satellite Healthcare
         16.3.1. Company Overview
         16.3.2. Product Portfolio
         16.3.3. SWOT Analysis
         16.3.4. Financial Overview
         16.3.5. Strategic Overview
   16.4. Rogosin Institute
         16.4.1. Company Overview
         16.4.2. Product Portfolio
         16.4.3. SWOT Analysis
         16.4.4. Financial Overview
         16.4.5. Strategic Overview
   16.5. Nipro
         16.5.1. Company Overview
         16.5.2. Product Portfolio
         16.5.3. SWOT Analysis
         16.5.4. Financial Overview
         16.5.5. Strategic Overview          
   16.6. Medtronic
         16.6.1. Company Overview
         16.6.2. Product Portfolio
         16.6.3. SWOT Analysis
         16.6.4. Financial Overview
         16.6.5. Strategic Overview      
   16.7. Nikkiso
         16.7.1. Company Overview
         16.7.2. Product Portfolio
         16.7.3. SWOT Analysis
         16.7.4. Financial Overview
         16.7.5. Strategic Overview
   16.8. Kawasumi Laboratories
         16.8.1. Company Overview
         16.8.2. Product Portfolio
         16.8.3. SWOT Analysis
         16.8.4. Financial Overview
         16.8.5. Strategic Overview
   16.9. JMS
         16.9.1. Company Overview
         16.9.2. Product Portfolio
         16.9.3. SWOT Analysis
         16.9.4. Financial Overview
         16.9.5. Strategic Overview
   16.10. Fresenius Medical Care
         16.10.1. Company Overview
         16.10.2. Product Portfolio
         16.10.3. SWOT Analysis
         16.10.4. Financial Overview
         16.10.5. Strategic Overview
   16.11. DaVita
         16.11.1. Company Overview
         16.11.2. Product Portfolio
         16.11.3. SWOT Analysis
         16.11.4. Financial Overview
         16.11.5. Strategic Overview  
   16.12. Baxter
         16.12.1. Company Overview
         16.12.2. Product Portfolio
         16.12.3. SWOT Analysis
         16.12.4. Financial Overview
         16.12.5. Strategic Overview
   16.13. B.Braun
         16.13.1. Company Overview
         16.13.2. Product Portfolio
         16.13.3. SWOT Analysis
         16.13.4. Financial Overview
         16.13.5. Strategic Overview
   16.14. Asahi Kasei
         16.14.1. Company Overview
         16.14.2. Product Portfolio
         16.14.3. SWOT Analysis
         16.14.4. Financial Overview
         16.14.5. Strategic Overview    

17. Pre and Post COVID-19 Impact
   17.1. Positive influence on the healthcare industry
   17.2. The financial disruption of the manufacturing sector
   17.3. Impact of COVID-19 on emerging companies
   17.4. Significant mandates in the healthcare regulations initiated by Satellite Healthcareinistrations
   17.5. The overall economic slowdown of the developing and developed nations

18. FutureWise SME Key Takeaway Points for Client

Tables

Figures